Nov 9, 2022

Get to know Pathologist Dr. Uma Kundu, who serves patients in Houston, Texas.
New York City, New York Nov 9, 2022 (Issuewire.com) - A seasoned pathologist, Dr. Kundu serves as an Associate Professor within the Department of Laboratory Medicine, Division of Pathology/Lab Medicine at The University of Texas MD Anderson Cancer Center in Houston, Texas.
As a faculty member at MD Anderson Cancer Center, she has truly enjoyed being an integral team member in cancer care. With a specific interest in endoscopic ultrasound-guided fine needle aspirations of the gastrointestinal tract, she also provides mentorship and teaching to residents and fellows in cytopathology along with collaborating on research protocols.
Throughout her academic career, Dr. Kundu graduated with her Bachelor of Science degree in Microbiology from Louisiana State University in 1999. She then went on to earn her medical degree from the Louisiana State University School of Medicine in New Orleans in 2004.
After completing a residency at the University of Texas Health Science Center at Houston from 2004-2008, she received her board certification in Anatomic and Clinical Pathology. She then went on to pursue a fellowship in surgical pathology at MD Anderson Cancer Center from 2008-2009.
Thereafter, from 2009-2010, Dr. Kundu completed a fellowship in cytopathology at MD Anderson Cancer Center and received her subspecialty board certification in Cytopathology in 2010.
Among her previous academic appointments include Assistant Professor within the Department of Cytopathology, Division of Pathology/Lab Medicine at The University of Texas MD Anderson Cancer Center (2010-2017); Research Associate within the Department of Pathology - Research, Division of Pathology/Lab Medicine at the Louisiana State University Lions Eye Center (2001 - 2001); and Research Associate within the Department of Pathology - Research, Division of Pathology/Lab Medicine at Pennington Biomedical Research Center (1997-2000).
Pathology is a branch of medical science that involves the study and diagnosis of disease through the examination of surgically removed organs, tissues, bodily fluids, and in some cases, the whole body. Pathologists are physicians who specialize in diagnosis and management and can help your primary care doctors make a diagnosis of your medical condition.
Among Dr. Kundu's various accolades include 1st Place poster presentation, Texas Society of Pathologists (2007); the LSU Alumni Scholarship, Louisiana State University (1996); and the LSU Top 100 Scholarship, Louisiana State University (1996).
On a more personal note, she is a mother to two wonderful children.
Learn More about Dr. Uma Kundu:
Through her findatopdoc profile, https://www.findatopdoc.com/doctor/508960-Uma-Kunda-internist-Woodland-CA-95695, or through The University of Texas MD Anderson Cancer Center, https://faculty.mdanderson.org/profiles/uma_kundu.html
About FindaTopDoc.com
FindaTopDoc is a digital health information company that helps connect patients with local physicians and specialists who accept your insurance. Our goal is to help guide you on your journey toward optimal health by providing you with the know-how to make informed decisions for you and your family.
Source :Uma Kundu, MD
This article was originally published by IssueWire. Read the original article here.
Chinese memory chip giant ChangXin Memory Technologies (CXMT) plans to invest 34.9 billion yuan (US$5.2 billion) in expansion, with a large portion of the capital going to domestic suppliers of chipmaking equipment, according to a source. The firm, listed on the Shanghai Stock Exchange’s Star Market, would spend 24.1 billion yuan on a new technology research and development project and another 10.8 billion yuan on the second phase of a wafer testing base, according to a Monday stock filing. The...
Citi Research has turned bullish on China’s 30-year government bonds, projecting that yields will fall further even as US Treasury yields climb. In a Monday research note, analysts at the Wall Street bank recommended that investors go long on China’s 30-year sovereign debt, saying they expected the yield to fall towards 1.8 per cent while the 10-year yield could edge towards 1.6 per cent. The analysts attributed the outlook to easing supply pressures and improved market dynamics for China’s...
Shares of Akeso surged after British drug maker AstraZeneca moved to advance the Chinese biotech firm’s flagship cancer drug, while a new deal from US giant Merck further underscored the sector’s global momentum amid easing fears of US curbs. AstraZeneca on Tuesday announced a US$2 billion equity investment in Florida-headquartered Summit Therapeutics, which holds the exclusive rights to develop and commercialise Akeso’s immunotherapy drug ivonescimab outside China. Summit and AstraZeneca would...
Domestic workers will receive a P500 increase in their monthly minimum wage under a new wage order in Central Visayas, the Department of Labor and Employment (DOLE) said Tuesday.
Global investors are turning to China again in search of alternatives to crowded US asset markets, with Pimco seeing Chinese bonds as one of the safest ways to diversify portfolios after sentiment towards the world’s second-largest economy “flipped 180 degrees”. The US-based asset manager, which oversaw more than US$2 trillion in assets by the end of June, had been pointing its clients, particularly those outside the United States, towards Chinese offshore bonds, according to its president,...
As the Philippines moves to include nuclear power in its energy mix, the Department of Energy (DOE) is pushing for a competitive procurement framework focused on strict grid readiness, staged delivery schedules, and rigorous pricing parameters.
Hong Kong welcomed four companies to start trading on Tuesday after they raised a combined HK$14.4 billion (US$1.83 billion) – but three opened below their offer prices, adding pressure to an already sluggish month for initial public offerings (IPOs). Automated equipment manufacturer RoboTechnik Intelligent Technology was the largest company to make its debut, having raised HK$5.18 billion, but its shares closed 4.9 per cent lower at HK$414.4 (US$52.82) after dropping as much as 9.8 per...
JPMorgan Chase, the world’s top bank by market capitalisation, plans to expand hiring and technology investment across mainland China and Hong Kong and is looking to take advantage of the city’s strengthening capital markets as well as its platform for serving companies operating in and out of the Chinese market, according to senior executives. CEO Jamie Dimon said the banking giant’s China-related business, measured by factors including client volume, has grown sharply over the past decade –...
Some securities companies have begun to clean up non-compliant overseas stock trading by mainland Chinese investors following a regulatory crackdown that started months ago with fines on Tiger Brokers and Futu Securities International. Orient Securities’ mainland-based clients that have trading accounts in its Hong Kong unit will be banned from buying stocks and transferring in funds starting on Wednesday, according to a notice to customers seen by the South China Morning Post. Guotai Junan...
US chip giant Advanced Micro Devices (AMD) has agreed to acquire World Labs, the artificial intelligence start-up founded by renowned Chinese-American computer scientist Li Fei-Fei, for US$8.2 billion in an all-stock deal, as the company steps up its rivalry with Nvidia. The acquisition, expected to close by the end of this year, would integrate World Labs’ research team and spatial-intelligence model expertise into AMD, according to an announcement on Monday. Li, a Stanford University professor...
The Manila Electric Company (Meralco) on Tuesday announced that it has started the bidding or competitive selection process (CSP) for suppliers of its 900-megawatt (MW) baseload power requirement.
The Department of Energy (DOE) said Tuesday the suspension of excise taxes on liquefied petroleum gas (LPG) and kerosene would provide direct relief to Filipino households amid elevated global oil prices.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.